Innovative Biotech Systems Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 15-11-2024
- Paid Up Capital ₹ 3.15 M
as on 15-11-2024
- Company Age 34 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.25 M
as on 15-11-2024
- Satisfied Charges ₹ 5.70 M
as on 15-11-2024
- Revenue 127.83%
(FY 2023)
- Profit 391.05%
(FY 2023)
- Ebitda -7.79%
(FY 2023)
- Net Worth 130.45%
(FY 2023)
- Total Assets 2.90%
(FY 2023)
About Innovative Biotech Systems
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.15 M.
The company currently has active open charges totaling ₹4.25 M. The company has closed loans amounting to ₹5.70 M, as per Ministry of Corporate Affairs (MCA) records.
Luv Kumar, Bushra Atrey, and Veena Renjen serve as directors at the Company.
- CIN/LLPIN
U74899DL1990PTC041606
- Company No.
041606
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Innovative Biotech Systems?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Luv Kumar  | Director | 26-Sep-1990 | Current |
| Bushra Atrey | Additional Director | 21-Mar-2024 | Current |
| Veena Renjen | Director | 26-Sep-1990 | Current |
Financial Performance of Innovative Biotech Systems.
Innovative Biotech Systems Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 127.83% increase. The company also saw a substantial improvement in profitability, with a 391.05% increase in profit. The company's net worth Soared by an impressive increase of 130.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovative Biotech Systems?
In 2023, Innovative Biotech Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Neelgagan Infotech Private LimitedActive 13 years 3 months
Luv Kumar and Bushra Atrey are mutual person
- Innovative Builders Private LimitedActive 32 years 9 months
Luv Kumar and Bushra Atrey are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 22 Apr 1992 | ₹1.40 M | Open |
The Pradeshiya Industrial And Investment Corpn. Of U.P. Ltd. Creation Date: 27 Jan 1992 | ₹2.85 M | Open |
The Pradeshiya Industrial And Investment Corpn. Of U.P. Ltd. Creation Date: 30 Apr 1992 | ₹5.70 M | Satisfied |
How Many Employees Work at Innovative Biotech Systems?
Unlock and access historical data on people associated with Innovative Biotech Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovative Biotech Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovative Biotech Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
